MST1R and neoplasm: In tumors with moderate levels of MET and RON co-expression, 1 mg/kg of PCMdt-MMAE is sufficient to inhibit tumor growth and prevent tumor regrowth for up to two weeks (Fig. 5b, c, and Table 2B).